These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

815 related articles for article (PubMed ID: 34758520)

  • 21. In vitro efficacy of imipenem in combination with six antimicrobial agents against Mycobacterium abscessus.
    Miyasaka T; Kunishima H; Komatsu M; Tamai K; Mitsutake K; Kanemitsu K; Ohisa Y; Yanagisawa H; Kaku M
    Int J Antimicrob Agents; 2007 Sep; 30(3):255-8. PubMed ID: 17616451
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The synergetic effect of Imipenem-clarithromycin combination in the Mycobacteroides abscessus complex.
    Takei S; Ihara H; Togo S; Nakamura A; Fujimoto Y; Watanabe J; Kurokawa K; Shibayama K; Sumiyoshi I; Ochi Y; Iwai M; Okabe T; Chonan M; Misawa S; Ohsaka A; Takahashi K
    BMC Microbiol; 2020 Oct; 20(1):316. PubMed ID: 33076820
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro activity of tedizolid against the Mycobacterium abscessus complex.
    Compain F; Soroka D; Heym B; Gaillard JL; Herrmann JL; Dorchène D; Arthur M; Dubée V
    Diagn Microbiol Infect Dis; 2018 Mar; 90(3):186-189. PubMed ID: 29217419
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Species identification of Mycobacterium abscessus subsp. abscessus and Mycobacterium abscessus subsp. bolletii using rpoB and hsp65, and susceptibility testing to eight antibiotics.
    Nie W; Duan H; Huang H; Lu Y; Bi D; Chu N
    Int J Infect Dis; 2014 Aug; 25():170-4. PubMed ID: 24932856
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Selection of Resistance to Clarithromycin in Mycobacterium abscessus Subspecies.
    Mougari F; Bouziane F; Crockett F; Nessar R; Chau F; Veziris N; Sapriel G; Raskine L; Cambau E
    Antimicrob Agents Chemother; 2017 Jan; 61(1):. PubMed ID: 27799212
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antimicrobial Susceptibility of
    Guo Y; Cao X; Yu J; Zhan Q; Yang J; Wu X; Wan B; Liu Y; Yu F
    Infect Drug Resist; 2020; 13():2001-2010. PubMed ID: 32617011
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Selected Mutations by Nemonoxacin and Fluoroquinolone Exposure Among Relevant Gram-Positive Bacterial Strains in Taiwan.
    Yang JJ; Cheng A; Tai HM; Chang LW; Hsu MC; Sheng WH
    Microb Drug Resist; 2020 Feb; 26(2):110-117. PubMed ID: 31478786
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rifabutin Acts in Synergy and Is Bactericidal with Frontline Mycobacterium abscessus Antibiotics Clarithromycin and Tigecycline, Suggesting a Potent Treatment Combination.
    Pryjma M; Burian J; Thompson CJ
    Antimicrob Agents Chemother; 2018 Aug; 62(8):. PubMed ID: 29760147
    [No Abstract]   [Full Text] [Related]  

  • 29. Activity of Oritavancin and Its Synergy with Other Antibiotics against
    Wang G; Tang J; Feng J; Dong W; Huo X; Lu H; Wang C; Lu W; Wang X; Chen H; Tan C
    Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34198513
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro activity of clarithromycin in combination with other antimicrobial agents against Mycobacterium abscessus and Mycobacterium massiliense.
    Zhang Z; Lu J; Liu M; Wang Y; Zhao Y; Pang Y
    Int J Antimicrob Agents; 2017 Mar; 49(3):383-386. PubMed ID: 28188830
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative in vitro activities of nemonoxacin (TG-873870), a novel nonfluorinated quinolone, and other quinolones against clinical isolates.
    Lauderdale TL; Shiau YR; Lai JF; Chen HC; King CH
    Antimicrob Agents Chemother; 2010 Mar; 54(3):1338-42. PubMed ID: 20065058
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multisite reproducibility of results obtained by the broth microdilution method for susceptibility testing of Mycobacterium abscessus, Mycobacterium chelonae, and Mycobacterium fortuitum.
    Woods GL; Bergmann JS; Witebsky FG; Fahle GA; Wanger A; Boulet B; Plaunt M; Brown BA; Wallace RJ
    J Clin Microbiol; 1999 Jun; 37(6):1676-82. PubMed ID: 10325306
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Economic Evaluation of Nemonoxacin, Moxifloxacin and Levofloxacin in the Treatment of Early Community-Acquired Pneumonia with Possible Pulmonary Tuberculosis.
    Zhao M; Chi Z; Pan X; Yin Y; Tang W
    Int J Environ Res Public Health; 2022 Apr; 19(8):. PubMed ID: 35457683
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Novel drug combination for Mycobacterium abscessus disease therapy identified in a Drosophila infection model.
    Oh CT; Moon C; Park OK; Kwon SH; Jang J
    J Antimicrob Chemother; 2014 Jun; 69(6):1599-607. PubMed ID: 24519481
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synergistic activities of tigecycline with clarithromycin or amikacin against rapidly growing mycobacteria in Taiwan.
    Huang CW; Chen JH; Hu ST; Huang WC; Lee YC; Huang CC; Shen GH
    Int J Antimicrob Agents; 2013 Mar; 41(3):218-23. PubMed ID: 23312605
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Omadacycline, Eravacycline, and Tigecycline Express Anti-Mycobacterium abscessus Activity
    Li A; He S; Li J; Zhang Z; Li B; Chu H
    Microbiol Spectr; 2023 Jun; 11(3):e0071823. PubMed ID: 37140428
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nontuberculous mycobacterial ocular infections--comparing the clinical and microbiological characteristics between Mycobacterium abscessus and Mycobacterium massiliense.
    Chu HS; Chang SC; Shen EP; Hu FR
    PLoS One; 2015; 10(1):e0116236. PubMed ID: 25581038
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical isolates of Mycobacterium abscessus in Guangzhou area most possibly from the environmental infection showed variable susceptibility.
    Zhuo FL; Sun ZG; Li CY; Liu ZH; Cai L; Zhou C; Zhang JZ
    Chin Med J (Engl); 2013; 126(10):1878-83. PubMed ID: 23673103
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The analysis of species identification and susceptibility testing of Mycobacterium abscessus].
    Nie W; Duan H; Huang H; Lu Y; Chu N
    Zhonghua Jie He He Hu Xi Za Zhi; 2014 Jul; 37(7):517-21. PubMed ID: 25262693
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tedizolid Activity Against Clinical
    Tang YW; Cheng B; Yeoh SF; Lin RTP; Teo JWP
    Front Microbiol; 2018; 9():2095. PubMed ID: 30245674
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 41.